Metraipolis › archive › dc_250d710ab449
Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety — Europe PMC PMID:41598573
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41598573
- DOI
- 10.3390/jcm15020634
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T20:26:00.557Z
- SHA-256 of the archived text
52d61389419c1214540a31d54f3aae6c7d65d552c5ec946db043e3649b7b941f- Stable URL of this page
https://metraipolis.com/documento/dc_250d710ab449
How to cite
Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety — Europe PMC PMID:41598573 — Europe PMC (en), https://europepmc.org/article/MED/41598573 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_250d710ab449 (Metraipolis archive dc_250d710ab449, sha256 52d61389419c1214540a31d54f3aae6c7d65d552c5ec946db043e3649b7b941f)
BibTeX
@misc{dc250d710ab449,
title = {Original Versus Generic Eltrombopag in Patients with Immune Thrombocytopenia: A Prospective Multi-Center Experience on Efficacy and Safety — Europe PMC PMID:41598573},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41598573},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_250d710ab449; sha256 52d61389419c1214540a31d54f3aae6c7d65d552c5ec946db043e3649b7b941f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598573. Agents can read the archived copy with the MCP tool read_document.